| abstract |
The present invention relates to formulations of lyso-phospholipids for use in medicine, in particular nasal formulations of lysophosphatidylcholine for treating, preventing and/or relieving one or more symptoms and/or signs of a 1) disease or condition of the eye, 2) a metabolic disorder or disease, 3) a disease or condition of the heart or circulatory system, 4) a cognitive disorder or disease, 5) a neurodegenerative disorder or disease, 6) an injury, disease or disorder of the brain, or 7) an inflammatory disease or condition. |